Cytosorbents Corp Stock OTC Bulletin Board
Equities
US23283X2062
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
05-09 | Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M | MT |
05-09 | Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024 |
Sales 2024 * | 39.52M 53.9M | Sales 2025 * | 46.83M 63.88M | Capitalization | 53.19M 72.55M |
---|---|---|---|---|---|
Net income 2024 * | -20M -27.28M | Net income 2025 * | -9M -12.28M | EV / Sales 2024 * | 1.35 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
-2.67
x | P/E ratio 2025 * |
-5.44
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 227B | |
+15.46% | 197B | |
+18.58% | 141B | |
+30.36% | 110B | |
+0.65% | 64.15B | |
+17.74% | 53.72B | |
+5.82% | 51.75B | |
+11.23% | 45.2B | |
+5.73% | 37.37B |